| Orion Pharma AG - Irinotecan Orion 300 mg/15 ml, Infusionskonzentrat |
| 59219 | | 03 | | Irinotecan Orion 300 mg/15 ml | | Infusionskonzentrat | | L01XX19 | | Irinotecan | | 07.03.2011 | | |
|
| Composition |
| irinotecani hydrochloridum trihydricum 300 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 15 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | Durchstechflasche(n) | PR | PR | A | | Yes |
|
